Key Insights Guardant Health's estimated fair value is US$39.63 based on 2 Stage Free Cash Flow to Equity Current share...
Guardant Health ( NASDAQ:GH ) First Quarter 2024 Results Key Financial Results Revenue: US$168.5m (up 31% from 1Q...
Revenue Growth and Enhanced 2024 Guidance Highlight Guardant Health's First Quarter Achievements